Relationship between expressions of ErbB oncogene family and clinicopathologic features in breast cancer
Lipin Liu
Abstract
Lipin Liu
Abstract
Objective To study the expression of oncogene erbB-1,erbB-2,erbB-3,erbB-4 in breast cancer and its value for prognosis. Methods The protein expression of erbB-1,erbB-2,erbB-3 and erbB-4 in 81 cases of breast cancer were examined by using paraffin-section immunohistochemistry. Results The patients were grouped by histological type,histological grade,lymph node metastasis and postoperative survival period. The difference in the positive rate of erbB-2 and 3 was significant among the histological grade,postoperative survival period and lymph node metastasis,respectively( P 0. 05 or P 0. 01),but not with histology type( P 0. 05); There was no statistical difference in the expression of erbB-1 and 4 among the four groups( P 0. 05); But the expression of erbB-2 compared to erbB-1,3 and 4 was obvious difference( P 0. 05 or P 0. 01). Conclusion The expression of erbB-2 and 3 were closely related to breast cancer growth, proliferation and metastasis,and can be regarded as an independent prognostic indicator; the expression of erbB-1,4 is synergistic in breast cancer growth. To analyze the expression of erbB-1 and 4 is valuable for the clinical diagnosis and treatment of breast cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the expression of oncogene erbB-1,erbB-2,erbB-3,erbB-4 in breast cancer and its value for prognosis. Methods The protein expression of erbB-1,erbB-2,erbB-3 and erbB-4 in 81 cases of breast cancer were examined by using paraffin-section immunohistochemistry. Results The patients were grouped by histological type,histological grade,lymph node metastasis and postoperative survival period. The difference in the positive rate of erbB-2 and 3 was significant among the histological grade,postoperative survival period and lymph node metastasis,respectively( P 0. 05 or P 0. 01),but not with histology type( P 0. 05); There was no statistical difference in the expression of erbB-1 and 4 among the four groups( P 0. 05); But the expression of erbB-2 compared to erbB-1,3 and 4 was obvious difference( P 0. 05 or P 0. 01). Conclusion The expression of erbB-2 and 3 were closely related to breast cancer growth, proliferation and metastasis,and can be regarded as an independent prognostic indicator; the expression of erbB-1,4 is synergistic in breast cancer growth. To analyze the expression of erbB-1 and 4 is valuable for the clinical diagnosis and treatment of breast cancer.
Key concepts: Medicine, Breast cancer, Immunohistochemistry, ErbB, Lymph node, Metastasis, Oncology, Oncogene